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Given that co-infection of cells with equivalent titers of inﬂuenza A and B viruses (FluA and FluB) has
been shown to result in suppression of FluA growth, it is possible that FluB-speciﬁc proteins might hinder
FluA polymerase activity and replication. We addressed this possibility by individually determining the
effect of each gene of FluB on the FluA polymerase assay and found that the nucleoprotein of FluB (NPFluB)
inhibits polymerase activity of FluA in a dose-dependent manner. Mutational analyses of NPFluB suggest
that functional NPFluB is necessary for this inhibition. Slower growth of FluA was also observed in MDCK
cells stably expressing NPFluB. Further analysis of NPFluB indicated that it does not affect nuclear import of
NPFluA. Taken together, these ﬁndings suggest a novel role of NPFluB in inhibiting replication of FluA,
providing more insights into the mechanism of interference between FluA and FluB and the lack of
reassortants between them.
& 2012 Elsevier Inc. All rights reserved.Introduction
Inﬂuenza virus types A and B (FluA and FluB) are orthomyx-
ovirus currently co-circulating in the human population, causing
signiﬁcant mortality and morbidity worldwide. Their viral gen-
omes consist of eight segments of single-stranded RNA of nega-
tive sense polarity, encapsidated as viral ribonucleoproteins
(vRNPs) by the nucleoprotein (NP) and the RNA-dependent RNA
polymerase complex comprising the PB2, PB1 and PA subunits
(Lamb and Choppin, 1983; Neumann et al., 2004). Upon infection,
vRNPs are released from an endocytosed virion in the late
endosome (Lakadamyali et al., 2003), and subsequently trans-
ported to the nucleus where transcription and replication of the
RNA genome takes place (Mikulasova et al., 2000; Neumann et al.,
2004). This includes the transcription of viral RNA (vRNA) into
mRNA, and the replication of vRNA into complementary RNA
(cRNA), the full-length intermediate which subsequently serves
as a template for vRNA synthesis. Although most, if not all,
knowledge regarding the transcription and replication processes
of inﬂuenza virus genome has been derived from inﬂuenza A
virus-based experiments, it has been presumed that inﬂuenza B
viruses undergo viral replication in a similar manner (Deng et al.,
2011; Wakai et al., 2011).ll rights reserved.
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wwattana).Despite being closely related, intertypic reassortants between
FluA and FluB have never been detected in nature or successfully
generated in vitro (Iwatsuki-Horimoto et al., 2008; Kaverin et al.,
1983; Mikheeva and Ghendon, 1982; Tobita and Ohori, 1979). The
molecular mechanism underlying this phenomenon is thus far
not clearly understood. Mounting evidence, however, suggests
that the lack of reassortants involves intertypic incompatibility
at the levels of RNA transcription and replication (Iwatsuki-
Horimoto et al., 2008; Wunderlich et al., 2011). It has been shown
that the polymerase complex of FluA or FluB can efﬁciently
recognize the promoter sequence derived from those of different
type (Crescenzo-Chaigneet al., 1999; Iwatsuki-Horimoto et al.,
2008). Earlier results have shown that polymerase assays where FluA
and FluB polymerase proteins were mixed failed to support poly-
merase activity in all combinations, indicating the importance of
compatibility among the polymerase subunits (Crescenzo-Chaigne
et al., 1999). Intriguingly, a more recent study reported that the PB2,
PB1 and NP of FluB strain B/Panama/45/90, but not those of B/Lee/40,
were compatible with the PA subunit of FluA (A/WSN/33) and able to
recognize the FluA promoter, giving rise to a polymerase activity
level comparable to that resulting from polymerase complexes
derived solely from FluA (Iwatsuki-Horimoto et al., 2008). In striking
contrast, a study by Wunderlich and colleagues demonstrated the
importance of the binding afﬁnity mediated by the FluA and FluB
PB1 subunit’s PA-binding domain in determining compatibility
between polymerase subunits (Wunderlich et al., 2011). When the
PB1 of FluB was engineered to harbor a PA-binding domain similar
to that of FluA, it failed to assemble with other subunits of FluB
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could be restored, polymerase activity was still impaired. This was
surprising since the PB1’s PA-binding domains of B/Lee/40 and B/
Panama/45/90 are identical (Genbank: BAA00002.1 and AAB72043.1),
and it is unlikely that the selective interaction between the PA of FluA
and PB1 of B/Panama/45/90, but not B/Lee/40, is due to a difference in
binding afﬁnity of the PA-binding domain of PB1 of both strains of
FluB. The discrepancies between these ﬁndings make it difﬁcult to
conceptualize the role of FluA and FluB polymerase complex compat-
ibility in the restriction of intertypic reassortment. This prompted us
to speculate that there might be other type-speciﬁc contributors,
besides PB1, PA or viral promoters, that also play a critical role in this
process.
The intrinsic interference between FluA and FluB was ﬁrst
described almost 60 years ago (Gotlieb and Hirst, 1954). Results from
a number of studies using various strains of FluA and FluB demon-
strated that co-infection of mammalian or avian cells with compar-
able titers of FluA and FluB not only failed to generate intertypic
reassortants, but also showed signiﬁcant suppression of FluA growth
(Aoki et al., 1984; Kaverin et al., 1983; Mikheeva and Ghendon, 1982;
Tobita and Ohori, 1979), thereby indicating a competitive interference
between them. Although FluB-mediated inhibition of FluA growth has
been shown to be at the level of viral transcription (Aoki et al., 1984;
Kaverin et al., 1983; Mikheeva and Ghendon, 1982), it is not known
whether FluB proteins are involved in this inhibitory effect. We thus
speculate that, upon co-infection of FluA and FluB, particular FluB
proteins might be able to block polymerase activity of FluA, leading to
suppression of FluA replication.
In view of this hypothesis, we investigated whether there exist
FluB proteins that can interfere with the replication of FluA. We
discovered that the NP of FluB (NPFluB) could inhibit polymerase
activity of FluA in a dose-dependent manner. Furthermore,
increasing the amount of NP of FluA was found to offset the
inhibitory effect of NPFluB, suggesting a possible competitive
mechanism between the two proteins. Our study also demon-
strated that the expression of NPFluB in host cells correlates with
lower viral growth of FluA. These ﬁndings collectively establish a
key and novel role for NPFluB in the inhibition of FluA replication,
providing an additional mechanism underlying the interference
between the two viruses.Results
FluB inhibits the replication of recombinant FluA harboring a
ﬂuorescence gene
Results from earlier studies showing FluB-mediated suppres-
sion of FluA replication are mostly based on RNA–RNA hybridiza-
tion or assessment of protein bands with radioactively labeled
amino acids in PAGE analyses (Aoki et al., 1984; Kaverin et al.,
1983; Mikheeva and Ghendon, 1982). While the migration pat-
tern of FluA and FluB proteins could be used to differentiate and
visually assess the expression of viral products, interpretation of
results can sometimes be difﬁcult, leading to conﬂicting conclu-
sions (Kaverin et al., 1983; Mikheeva and Ghendon, 1982). As
recombinant inﬂuenza viruses encoding ﬂuorescent proteins in
their genome have been widely used to assess viral replication
in live cells (Martinez-Sobrido et al., 2010; Ozawa et al., 2011;
Rimmelzwaan et al., 2011), we co-infected Vero E6 cells with FluB
(B/Lee/40), and recombinant FluA engineered to replace the
neuraminidase (NA) coding sequence with DsRed (FluADsRed)
and monitored the expression of red ﬂuorescent protein by ﬂow
cytometry. As early as 5 h after infection, we detected more
ﬂuorescent cells, as well as substantially stronger DsRed signals,
when cells were infected by FluADsRed alone compared to thoseinfected simultaneously with FluB (Fig. 1A). Reduction of DsRed
signal was not due to a dilution effect during co-infection as cells
co-infected with FluADsRed and A/PR/8/34 showed no difference in
both DsRed signal and the number of ﬂuorescent cells (Fig. 1B).
Notably, when B/Maryland/2/59 was used to co-infect MDCK cells
with FluADsRed, signiﬁcant DsRed signal loss similar to those co-
infected with B/Lee/40 was observed, suggesting that the inhibi-
tion of FluADsRed replication mediated by FluB is not strain-
speciﬁc (Fig. 1C).
Furthermore, in congruence with an earlier report (Aoki et al.,
1984), when Vero E6 cells were pre-infected with FluADsRed
followed by infection with FluB 2 h later, the reduction of DsRed
signal was not detected (Fig. 1D). It is possible that the inability of
FluB to inhibit DsRed signals of cells pre-infected with FluADsRed
may be attributed to a mechanism to prevent superinfection as
cell surface NA expressed by the virus that initiated infection
would act to remove sialic acid on the cell surface (Huang et al.,
2008). The use of FluADsRed in our study proves this possibility
unlikely as this recombinant virus has no functional NA. These
results agree with others that FluB likely exerts its inhibitory
effect early after co-infection.
Inhibition of FluA polymerase activity is mediated by NPFluB
To determine whether the transcription activity of FluA could be
inhibited by FluB proteins expressed during co-infection, we
employed an in vitro polymerase assay to mimic the transcription
of FluA and analyzed the reporter readout in the presence of each
FluB protein. As shown in Fig. 2A, inclusion of a plasmid expressing
NPFluB (pHW2000-NPLee) resulted in a considerable decline in FluA
polymerase activity, while other FluB proteins showed only mar-
ginal effects, if any. Of note, FluB plasmids tested in this study were
successfully used to rescue infectious FluB in vitro, thereby suggest-
ing that all FluB proteins could be expressed by these plasmids. To
further determine the inhibitory effect of NPFluB, we added increas-
ing amounts of pHW2000-NPLee plasmid to the FluA polymerase
assay and detected a reduction of FluA polymerase activity in a
dose-dependent manner (Fig. 2B). To rule out the possibility that the
UTR present in the pHW2000-NPLee might compete with the FluA
UTR in the polymerase assay, we engineered pHW2000-NPLee
further by removing the open reading frame of NPLee (NPFluBDORF)
and tested the inhibitory effect of this plasmid in the FluA poly-
merase assay. As expected, no inhibition of FluA polymerase activity
was detected in the presence of this plasmid construct (Fig. 2C). It is
also worth noting that increasing the amount of plasmid expressing
NP of PR8 (pHW2000-NPPR8) did not result in any perceptible
change in polymerase activity of FluB (Fig. 3A), but was able to
restore the polymerase activity in the presence of pHW2000-NPLee
(Fig. 3B). In fact, increasing amounts of individual plasmid expres-
sing polymerase proteins of PR8, including PB2, PB1 and PA, did not
lead to a resumption of the transcription inhibition by NPFluB in the
same fashion as NPFluA (Fig. 3C). These ﬁndings collectively suggest
that NPFluA could offset the inhibition mediated by NPFluB in the FluA
polymerase assay.
To further verify the inhibitory ability of NPFluB in a virus
infection context, we used FluADsRed to infect HEK293T cells that
were pre-transfected with pHW2000-NPLee and assessed the
expression of DsRed at various time points after infection. At
5 h after infection, the expression of DsRed was clearly sup-
pressed in cells pre-transfected with pHW2000-NPLee (Fig. 3D).
However, at a later time point (12 h after infection), the difference
in DsRed expression was less pronounced (Fig. 3D). This result
supports the notion that NPFluA can counteract NPFluB, as the amount
of NPFluA accumulated in FluA-infected cells would eventually surpass
the NPFluB, generated from the transfected plasmid. Taken together,
these results suggest that NPFluB could suppress the polymerase
Fig. 1. Inhibition of FluADsRed replication by FluB. Vero E6 cells were either infected with FluADsRed alone or co-infected with FluADsRed and (A) B/Lee/40, (B) A/PR/8/34, or
(C) B/Maryland/2/59. Infection was carried out using MOI of 0.1 for each virus. (D) Vero E6 cells were either infected simultaneously with FluADsRed and B/Lee/40 or pre-
infected with FluADsRed 2 h prior to subsequent infection with B/Lee/40. Infection was carried out using MOI of 0.1 for each virus. Expression of DsRed protein in infected
cells were visualized and photographed using a ﬂuorescence microscope at 5 h after infection. Subsequently, cells were harvested, ﬁxed in 2% parafamaldehyde and
subjected to ﬂow cytometry analysis.
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access to the FluA transcription machinery.
Full-length NPFluB is required for its inhibitory ability
It can be speculated from our data that NPFluB might exert its
inhibitory effect on the FluA polymerase machinery as a compe-
titive inhibitor of NPFluA. If so, it is possible that NPFluB might
compete with NPFluA to interact with components of the FluA
polymerase complex. While the protein domains required for
protein–protein interaction of NPFluA have been identiﬁed and
studied extensively (Kobayashi et al., 1994; Ng et al., 2008; Ye
et al., 2006), it is very recently that the crystal structure of NPFluB
has been resolved (Ng et al., 2012). In an attempt to search for the
domain of NPFluB responsible for its inhibitory property, we
engineered pHW2000-NPLee to generate various constructs by
deleting various domains of NPFLuB including the N terminus
(DN70), the ﬂexible charged loop (D125–146) and the tail loop
(D458–484) (Fig. 4A) and evaluated their inhibitory effect on the
FluA polymerase assay. To our surprise, all of the constructs
generated in our study failed to exhibit any inhibitory effect,
unlike the full-length NPFluB (Fig. 4B). Moreover, consistent with
results reported earlier (Ng et al., 2012), all truncated constructs
were unable to provide detectable polymerase activity in the FluB
polymerase assay (Fig. 4C), conﬁrming that the transcription
function was impaired in these truncated variants. To addresswhether the observed loss of activity was due to compromised
protein structure or poor expression of the modiﬁed proteins, we
transfected each plasmid construct and assessed its expression
using western blot and immunoﬂuorescence microscopy. We could
detect high expression of NPFluB with DN70 and D125–146 con-
structs but not with the D458–484 variant, which was also
conﬁrmed by immunoﬂuorescence analysis (Fig. 4D). Intriguingly,
we observed that NPFluBDN70 and NPFluBD125–146 were mostly loca-
lized in the cytoplasm while wild-type NPFluB was found predomi-
nantly in the nucleus of transfected cells (Fig. 4D). The cytoplasmic
localization of NPFluBDN70 and NPFluBD125–146 might thus be respon-
sible for their inability to support the polymerase activity in this
study. It should also be noted that, in contrast to our ﬁnding here,
N-terminally truncated NPFluB constructs similar to this study have
been generated previously and their expressions was found to
accumulate within the nuclear compartment (Deng et al., 2011;
Stevens and Barclay, 1998). The mechanism underlying these
differences is, however, not known. These results suggest that the
full-length and functional NPFluB is required to inhibit the polymer-
ase activity of FluA.
Replication of FluA in MDCK cells stably expressing NPFluB is
moderately suppressed
We next addressed the question as to whether NPFluB stably
expressed in MDCK cells will render those cells less susceptible to
Fig. 2. NPFluB plays a key role in the inhibition of FluA polymerase activity. (A) A pHW2000 plasmid expressing each gene of B/Lee/40 (500 ng) was included in the FluA
polymerase assay using pHW2000 expressing PB2, PB1, PA and NP (500 ng each) derived from A/PR/8/34 and PolI-sNA-GFP reporter (FluA-UTRs) (500 ng). Polymerase
activity was determined based on NA activity in the supernatants at 48 h after transfection. Relative polymerase activity was normalized to the activity obtained from cells
transfected with plasmids expressing polymerase proteins and NPPR8 together with pHW2000 plasmid without FluB gene (empty). (B) The FluA polymerase assay was
carried out in combination with various concentrations of pHW2000-NPLee. Lysates of transfected cells were subjected to western blot using anti-NPFluB and anti-b-actin
antibodies. (C) pHW2000-NPLee and the modiﬁed plasmid, pHW2000-NPFluBDORF, were tested in the FluA polymerase assay.
A. Wanitchang et al. / Virology 432 (2012) 194–203 197FluA infection. Full-length NPFluB of B/Lee/40 was introduced into
MDCK cells using a retrovirus-based transduction system. Selected
clones were subjected to western blotting for NPFluB expression and
the clone with the highest expression (MDCK-NPFluB#4) was chosen
for further analysis (Fig. 5A). Of note, western blot of normal MDCK
cell lysates showed no expression of NPFluB (data not shown). We
then assessed the replication of various strains of FluA in MDCK-
NPFluB#4 in comparison with normal MDCK cells. As shown in
Fig. 5B, the replication of FluA, as indicated by NPFluA expression,
was moderately suppressed in MDCK-NPFluB#4. Interestingly, when
MDCK cells were simultaneously infected with an equal MOI of FluA
and FluB, the level of NPFluA expression was greatly diminished
(Fig. 5C). Since NPFluB expression in MDCK-NPFluB#4 is substantially
lower than in FluB-infected cells (Fig. 5A), it is not surprising to see a
rather moderate effect of inhibition in MDCK-NPFluB#4. Indeed, this
observation is in agreement with our previous results that suggest
the dose-dependent ability of NPFluA to counterbalance the inhibi-
tory effect imposed by NPFluB (Fig. 3B). If, as hypothesized, NPFluB
stably expressed in MDCK-NPFluB#4 could suppress FluA replication,
inhibition of FluA replication in MDCK-NPFluB#4 co-infected with
FluB would be more pronounced than that observed in normal
MDCK cells. As expected, the expression of NPFluA in MDCK-
NPFluB#4 co-infected with FluA and FluB was greatly reduced
when compared with normal MDCK cells co-infected with the
same dose of viruses (Fig. 5C). These results were also veriﬁed by
a marked decline of DsRed signal in MDCK-NPFluB#4 co-infectedby FluADsRed and FluB (data not shown). Taken together, these
results indicate that NPFluB mediates FluB-mediated inhibition of
FluA replication in co-infected cells.
NPFluB does not block nuclear import of NPFluA
Results from previous experiments suggest that NPFluB might
exert its inhibitory activity by targeting at NPFluA. Given that
NPFluA has been shown to be a multifunctional protein playing a
critical role in several steps of inﬂuenza virus replication, disrup-
tion of its activity could thus adversely affect viral replication.
Shortly after the cytoplasmic release of the vRNP complexes,
NPFluA is known to facilitate the import of vRNP into the host’s
nucleus via its nuclear localization signals (Cros et al., 2005;
Neumann et al., 1997; Ozawa et al., 2007; Wu et al., 2007). Since
data from previous studies as well as those presented in this
study indicate that FluB inhibits FluA polymerase activity, it is
possible that NPFluB might interact with NPFluA in the cytoplasm
and, in turn, hinder the nuclear translocation of NPFluA. To test
this hypothesis, we performed immunoﬂuorescence analysis of
HEK293T cells co-transfected with plasmids expressing NPFluA
and NPFluB, and assessed the localization of both proteins in a
single cell. To facilitate the detection of proteins, we transfected
cells using plasmids expressing HA-tagged NPFluA and Myc-tagged
NPFluB in this experiment. As depicted in Fig. 6, virtually all cells
expressing both NPFluA and NPFluB were found to be localized in
Fig. 3. NPFluA partially counteracts the NPFluB-mediated inhibition of the FluA polymerase assay. (A) The FluB polymerase assay was performed by transfecting HEK293T cells
with pHW2000 expressing PB2, PB1, PA and NP derived from B/Lee/40 and the PolI-sNA-GFP reporter (FluB-UTRs) together with various concentrations of pHW2000-NPPR8.
(B) The FluA polymerase assay was performed with various concentrations of pHW2000-NPPR8 in the presence or absence of pHW2000-NPLee. Lysates of transfected cells were
subjected to western blot analysis using anti-NPFluA and anti-b-actin antibodies. (C) The FluA polymerase assay was carried out with various concentrations of PB2, PB1, PA and
NP (derived from A/PR/8/34) in the presence of pHW2000-NPLee (NPFluB). (D) HEK293T cells were transfected with pHW2000-NPLee (1 mg) 4 h before being subsequently infected
by FluADsRed. At 5 and 12 h after infection, expression of DsRed was visualized and photographed.
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effect on the nuclear import of NPFluA and it likely exerts its
inhibitory effect in the host cell’s nucleus.Discussion
When a host cell is co-infected by a comparable infectious
dose of FluA and FluB, vRNPs of both viruses must be imported
into the nucleus to initiate the transcription of their segmented
genomic RNAs. Several pieces of evidence indicate that this early
step of virus replication is when the interference between FluA
and FluB occurs (Aoki et al., 1984; Kaverin et al., 1983; Mikheeva
and Ghendon, 1982). By an as-yet unidentiﬁed mechanism,
transcription of FluA is strongly suppressed, resulting in a sharp
decline of protein synthesis and eventually inhibition of viral
growth (Aoki et al., 1984; Mikheeva and Ghendon, 1982). Onlyproteins in the viral polymerase subunits (PB2, PB1, PA) and the
NP are believed to be present in the nucleus at this stage, and if
inhibition is mediated at the protein level without complication
from host proteins, it is reasonable to postulate that interaction
between one or more of these proteins would be accountable for
this inhibitory effect. We demonstrated in this study, for the ﬁrst
time to our knowledge, that NPFluB, but not the polymerase
subunits, plays a pivotal role in the inhibition of the FluA
transcription machinery by FluB. It is also clear from our results
that this property is speciﬁc for NPFluB, as a similar effect was
observed with NP derived from at least two strains of FluB but not
with NPFluA. Indeed, we found that no FluA protein was able to
block the polymerase activity of FluB in a manner similar to NPFluB
(data not shown). Our data also suggests that full-length NPFluB is
required to exhibit its inhibitory effect. Since all of the NPFluB
constructs tested in this study are truncated and are unable to
generate detectable polymerase activity in the FluB polymerase
Fig. 4. Full-length and functional NPFluB is required for the inhibition of FluA polymerase activity. (A) Schematic representation of truncated NPFluB constructs generated
and tested in this study. (B) pHW2000 plasmids expressing full-length or truncated NPFluB were used to assess its inhibitory effect in the FluA polymerase assay. The
polymerase activity was determined at 48 h after transfection and relative polymerase activity was calculated by normalizing to the activity obtained from the cells
transfected with plasmids expressing polymerase proteins and NPPR8 together with pHW2000 plasmid without FluB gene. (C) pHW2000 plasmids expressing full-length or
truncated NPFluB were used to assess its functionality in the FluB polymerase assay by replacing the pHW2000-NPLee with a plasmid expressing each truncated variant.
(D) Plasmids expressing full-length and truncated NPFluB were transfected into HEK293T cells. At 48 h after transfection, cells were harvested and subjected to western blot
analysis using anti-c-Myc and anti-b-actin antibodies. Alternatively, cells were ﬁxed and subjected to immunoﬂuorescence analysis.
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NPFluB variants harboring mutations known to impair its activity
would behave likewise.
The fact that increasing expression of NPFluA could, at least
partially, lead to alleviation of transcription inhibition by NPFluB
prompts us to speculate that NPFluB might interact, at least
indirectly, with NPFluA before or during the transcription of FluA
vRNA. NPFluA has at least two highly conserved nuclear localiza-
tion signals (NLS), designated NLS1 (residues 3–13) and NLS2
(residues 198–216) (Wu et al., 2007). In particular, NLS2, which is
a signal for NP localization to a nucleolar compartment, has been
shown to be critical for vRNA transcription (Ozawa et al., 2007). In
contrast, much less information is available for NPFluB with
regards to the subcellular/subnuclear localization and regulation
of vRNA transcription. Although it has been shown that NPFluB
is also localized in the nucleus, its NLS has not been clearly
identiﬁed (Deng et al., 2011; Stevens and Barclay, 1998). To
determine whether the expression of NPFluB would affect the
nuclear import of NPFluA and, presumably, vRNP, we used immu-
noﬂuorescence to monitor the localization of NPFluA and NPFluBafter co-transfection of plasmids expressing each protein into a
single cell. It is clear from our results that NPFluB hardly affected
the nuclear translocation of the NPFluA (Fig. 6). This ﬁnding
suggests that NPFluB exerts its inhibition effect in the host cell’s
nucleus.
Our data presented here cannot rule out the possibility that
the presence of both types of NP may compete for the same host
factor, resulting in the inhibition of one another’s activity. The
results that increasing amount of NPFluA could partially counteract
the inhibitory effect of NPFluB could possibly due to its ability to
bind to host proteins required for NPFluB to exert its inhibitory
effect. Furthermore, the co-localization of NPFluA and NPFluB
within the nuclear compartment also suggests that, if true, the
two proteins may interact with the host protein within the
nucleus. Additional studies are needed to determine whether
NPFluB-mediated suppression of FluA polymerase activity depends
on the host protein.
Even though it has been shown, using an in vitro transcription
assay, that NP is not required for the initiation cRNA synthesis in a
step so-called replicative transcription (Lee et al., 2002), a number
Fig. 5. FluA grows slowly in MDCK cells stably expressing NPFluB. (A) Western
blot analysis showing NPFluB expression in selected clones of MDCK cells
transduced by pseudotyped retrovirus expressing full-length NPFluB. Lysates
obtained from FluB-infected MDCK cells served as a positive control (þ).
(B) Expression of NPFluA, determined by NP ELISA, in normal MDCK cells and
MDCK cells expressing NPFluB infected with A/PR/8/34 (H1N1) or A/Nonthaburi/
102/09 (H1N1) using MOI¼0.1. (C) Expression of NPFluA in normal MDCK cells
and MDCK cells expressing NPFluB co-infected with A/PR/8/34 and B/Lee/40 at
various MOI.
Fig. 6. NPFluB does not affect nuclear accumulation of NPFluA. HEK293T cells were
co-transfected with pHW2000-NPPR8 and pCMV-HA-NPLee. At 48 h after transfec-
tion, cells were ﬁxed and subjected to immunoﬂuorescence analysis using rabbit
anti-NPFluA and mouse anti-HA tag antibodies. Subcellular localization of NPFluA
and NPFluB was determined by ﬂuorescence microscopy.
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several steps of the viral transcription. NPFluA is known as an
essential factor during the elongation of the RNA chain as it is
required for the transcription of full-length genome segments
(Honda et al., 1988). Moreover, monoclonal antibodies against
NPFluA have been shown to signiﬁcantly inhibit the transcriptional
activity of FluA, and later demonstrated to interfere with the
initiation step of mRNA-primed transcription (Barcena et al.,
1994). Several lines of evidence also indicate that NPFluA could
interact with the PB2 subunit through multiple regions (Biswas
et al., 1998; Poole et al., 2004; Portela and Digard, 2002).
However, whether this interaction plays any role in the cap-
snatching process is not known. Interestingly, it was found thatthe NP- and PB1-binding sites located at the N and C terminal
regions of the PB2 subunit overlap and that this region of PB2 was
also reported to be involved in mRNA cap binding (Poole et al.,
2004). With its considerable degree of similarity, NPFluB might be
able to interact with the PB2 subunit of FluA in a similar manner.
If so, NPFluB might exert its inhibitory effect by competing with
NPFluA to bind with the polymerase subunits of FluA. Unfortu-
nately, currently available data on the compatibility between the
FluA PB2, PB1 and PA subunits and NPFluB are conﬂicting. While
our unpublished data seem to agree with those reported by Cres-
cenzo-Chaigne et al., where polymerase assays using FluA polymer-
ase subunits and NPFluB result in relatively low, yet detectable,
activity (Crescenzo-Chaigneet al., 1999), a similar assay carried out
by Kiyoko Iwatsuki-Horimoto and colleagues showed undetectable
activity (Iwatsuki-Horimoto et al., 2008). It thus remains unclear as to
whether NPFluB can compete with NPFluA to interact with the FluA
transcriptional complex and whether it contributes to the block of
FluA replication via this mechanism.
Another possible mechanism of NPFluB-mdediated inhibition
of FluA replication is through a direct interaction with NPFluA.
Indeed, inhibition of NPFluA activity in the nucleus by interaction
with other proteins during viral transcription has been reported.
When MxA, a human homolog of Mx1, was fused to the trans-
activation domain of herpes simplex virus VP16 (termed VP16-
MxA) or engineered to harbor the NLS of SV40 T antigen (termed
MxA-TAg NLS) and subsequently used to examine its effect on the
FluA polymerase assay, it was found that reporter activity was
signiﬁcantly reduced (Turan et al., 2004). Interestingly, MxA-
mediated inhibition of viral transcription was found to be com-
pletely neutralized by the over-expression of NPFluA. It has been
proposed from this study that MxA and NPFluA might interact with
each other through a rather weak interaction or possibly bridged
by one or more mediator molecules in a complex. Though not
directly indicated, inhibition of the primary transcription of
inﬂuenza virus by the murine Mx1 protein might occur through
interaction with NPFluA as well (Krug et al., 1985). Moreover, the
transport of vRNP into the nucleus was found to be unaffected in
cells expressing nuclear Mx1 protein (Broni et al., 1990), which
ﬁts well with what we observed with NPFluB. In spite of several
similarities between our ﬁnding and what has been previously
reported in the MxA/Mx1 studies, we cannot conclude at this
stage whether or not NPFluB suppresses FluA replication by the
same mode of action. Further studies are required to elucidate the
A. Wanitchang et al. / Virology 432 (2012) 194–203 201interaction between NPFluA and NPFluB at a molecular level, which
should help address this possibility in more detail.
In conclusion, our results underscore the critical function of
NPFluB in the intertypic interference between FluA and FluB and
deﬁne its role in the suppression of FluA polymerase activity in
the host’s nucleus early after co-infection. More importantly, our
data provide an additional explanation for the exclusion of
reassortment between FluA and FluB. We demonstrate that the
inhibitory effect mediated by interaction between type-speciﬁc
proteins, most likely NPFluB and its interacting partners, during
co-infection clearly plays a key role in this phenomenon.Materials and methods
Cells and viruses
Human embryonic kidney (HEK293T), Madin–Darby canine
kidney (MDCK) and Vero E6 (ATCC CRL-1586) cells were cultured
in Opti-MEM medium (Invitrogen, Carlsbad, CA) supplemented
with 10% heat-inactivated fetal bovine serum (FBS) and antibio-
tics at 37 1C under a humidiﬁed 5% CO2 atmosphere. Inﬂuenza A
viruses A/PR/8/34 (H1N1, PR8), A/Nonthaburi/102/09 (H1N1), as
well as inﬂuenza B viruses B/Lee/40 and B/Maryland/2/59 were
propagated in 10-day-old embryonated chicken eggs for 48 h at
37 1C. Allantoic ﬂuids were harvested and cleared by centrifuga-
tion at 10,000  g for 10 min. Supernatants were collected and
stored at 80 1C. Virus titer was determined by plaque or TCID50
determination assays. Reverse genetics-derived inﬂuenza A virus
(6PR8þHA of H5N1) harboring DsRed in the segment 6 con-
structed following the strategy described by (Rimmelzwaan et al.,
2007) was provided by Dr. Sriwan Wongwisansri (BIOTEC). The
virus was propagated in MDCK cells supplemented with 0.05 U/
ml sialidase derived from Vibrio cholerae (Roche Applied Science,
Mannhein, Germany).
Plasmid construction
The construction of pHW2000 plasmids expressing all eight
segments of B/Lee/40 was carried out as previously described
(Hoffmann et al., 2000) with slight modiﬁcations. In brief, full-
length cDNA of each gene was generated by RT-PCR (TAKARA Bio,
Japan) from viral RNA using primer pairs designed previously
(Hoffmann et al., 2002). PCR products were digested with appro-
priate enzymes before cloning into pHW2000 plasmid. To gen-
erate plasmids expressing NPLee bearing Myc tag at its C terminus,
full-length NP was PCR-ampliﬁed using primers designed to
harbor Myc tag sequence and the PCR products were subcloned
into pHW2000 vector. For plasmid expressing NPLee bearing HA
tag at its N terminus, full-length PCR product was subcloned into
pCMV-HA-N vector (Clontech, Mountain View, CA) To generate
pHW2000 plasmids expressing truncated constructs of was sub-
ject to inverse PCR using primer pairs designed to remove speciﬁc
region in the full-length NPLee. For the N-terminally truncated
constructs, the forward primers designed to introduce a start
codon containing the Kozak sequence at the desired position were
used in combination with a reverse primer covering the C
terminal end of the gene to generate the truncated fragments.
Sequences of all primers used in this study are available upon
request. The PCR reaction was carried out using KAPA HiFi PCR kit
(KAPA Biosystems, Woburn, MA) by following the manufacturer’s
protocol. The obtained plasmids were subsequently sequenced to
ensure that the mutations were properly introduced and that no
unwanted mutations were present.
To construct a plasmid for retroviral pseudotype expressing
NPFluB, full-length NPLee was PCR-ampliﬁed from pHW2000-NPLeeusing primers containing NotI and BamHI restriction sites, double-
digested and inserted into pQCXIH retroviral vector (Clontech).
Plasmids were subsequently used to replace pHW2000-NPLee in
the FluB polymerase assay (see next section) and the clone with the
highest polymerase activity was selected for further application.
Inﬂuenza virus polymerase assay
Unless noted otherwise, the experiments were carried out as
described previously (Wanitchang et al., 2011; Wanitchang et al.,
2011). Brieﬂy, HEK293T cells were transiently transfected with a
set of plasmids expressing PB2, PB1, PA and NP (derived from
A/PR/8/34 or B/Lee/40) together with a polymerase I (Pol I)-driven
plasmid expressing an inﬂuenza virus-like RNA coding for
secreted NA globular head (sNA) and green ﬂuorescent protein
(GFP), with the two genes separated by an internal ribosomal
entry site (IRES). These reporter RNA-coding sequences were
ﬂanked by untranslated regions of segment 7 of FluA or FluB. To
normalize variation in transfection efﬁciency, the transfection
mixture also included pCMV-mCherry (Clontech). Polymerase
activity was assessed by visually monitoring the expression of
GFP using ﬂuorescent microscopy or by quantifying NA activity in
the supernatant using 20-(-4methylumbelliferyl)-a-D-N-acetyl-
neuraminic acid (MU-NANA, Sigma, St. Louis, MO) as described
elsewhere (Wanitchang et al., 2010).
NP ELISA
Detection of NPFluA and NPFluB expression in infected MDCK
cells by ELISA was carried out as described previously (Kitphati
et al., 2009; Lerdsamran et al., 2011) with slight modiﬁcation.
Brieﬂy, MDCK cells were seeded in a 96-well tissue plate. At
conﬂuence, virus suspension (MOI¼0.1) was added onto the
MDCK cell monolayer, incubated at 37 1C for 1 h, washed,
replaced with Opti-MEM medium with TPCK-treated trypsin
(2 mg/ml) and incubated at 37 1C for 20 h. Expression of viral NP
in infected MDCK cells was assessed using mouse monoclonal
antibodies to NPFluA (Clone A1, Chemicon/Millipore Billerica, MA),
or NPFluB clone 4H7 (Abcam Cambridge UK) followed by HRP-
conjugated goat anti-mouse IgG (Santa Cruz Biotechnology, Santa
Cruz, CA). TMB (3,30,5,50-tetramethylbenzidine) substrate solution
(Bioﬁx, MD) was used as the chromogenic substrate. The reaction
was stopped with 1 M H2SO4, and color development was
measured on a microplate reader at 450 nm.
Retrovirus production and generation of MDCK cells stably
expressing NPFluB
GP2-293 packaging cells (Clontech) (1106 cells/well) were
seeded in a 6-well tissue culture plate 12 h before being trans-
fected with a retroviral vector encoding NPFluB (2 mg) together
with a plasmid encoding VSV-G (1 mg) using the Fugene HD
transfection reagent (Roche) following the manufacturer’s proto-
col. Viral supernatants were harvested 48 h after transfection and
added to MDCK cells in the presence of polybrene (8 mg/ml;
Sigma). Hygromycin B (750 mg/ml; PAA laboratories, Linz, Austria)
was added to the culture media at 24 h after retroviral transduc-
tion. Clones of resistant cells were pooled and subjected to serial
dilution to obtain a single cell line.
Western blot
Cells were harvested and solubilized in mammalian cell lysis
buffer (50 mM Tris–HCl, pH 8.0, 100 mM NaCl, 5 mM EDTA, 1%
NP40) supplemented with protease inhibitors (Roche). Proteins in
the lysates were separated by SDS-PAGE and transferred onto
A. Wanitchang et al. / Virology 432 (2012) 194–203202nitrocellulose membrane (GE Healthcare, Piscataway, NJ). The
membranes were blocked with 5% skimmed milk in TBS (pH 7.4)
and incubated for 1 h at room temperature with one of the
following antibodies: anti-NPFluA mouse monoclonal antibody
clone A1 (Chemicon/Millipore), anti-NPFluB mouse monoclonal
antibody clone 4H7 (Abcam), anti-c-myc mouse monoclonal
antibody clone 289-19510 (Invitrogen, Carlsbad, CA), anti-GFP
rabbit polyclonal antibody (Santa Cruz Biotechnology), and anti-
b-actin mouse monoclonal antibody clone C-4 (Santa Cruz Bio-
technology). The membranes were then washed and incubated
with HRP-conjugated anti-mouse or rabbit IgG (Santa Cruz
Biotechnology) for 1 h at room temperature. The signal was
developed using the SuperSignal West Pico kit (Thermo Scientiﬁc,
Rockford, IL).
Immunoﬂuorescence microscopy
HEK293T cells (1104 cells) were seeded on glass 8-well Lab-
Tek chamber slides (Nunc, Denmark) 12 h before transfection. At
24 h after transfection with indicated plasmids, the samples were
ﬁxed in ice-cold acetone for 5 min and blocked with 10% FBS plus
1% BSA in PBS at room temperature for 1 h. After blocking, the
cells were incubated with mouse monoclonal anti-Myc (Invitro-
gen) or rabbit anti-HA polyclonal antibodies (Abcam) diluted in
1% BSA at room temperature for 1 h, followed by washing with
PBS and incubation with FITC-conjugated goat anti-mouse IgG
(Abcam) or Texas-red-conjugated goat anti-rabbit IgG antibodies
(Abcam) diluted in 1% BSA for 1 h. After washing, slides were
mounted in Vectorshield containing DAPI (Vector Laboratories,
Burlingame, CA) and examined microscopically.
Statistical analysis
Values are expressed as the mean7SEM of at least three
independent assays and analyzed for statistical signiﬁcance using
an unpaired two-tailed Student t test. The p valuesr0.05 were
considered statistically signiﬁcant.Acknowledgments
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